About Me
I am a hematologist who specializes in treating patients suffering from acute and chronic myeloid diseases, particularly acute myeloid leukemia (AML). I was named to the Castle Connolly list of “Regional Top Doctors” in 2019, as well as being rated in the top 10 percent of physicians in the nation for patient satisfaction in 2017.
I received my medical degree and Master of Science in Clinical Research (MSCR) from the Medical University of South Carolina and then completed a combined fellowship in medical oncology/translational research here at The Ohio State University, where I currently serve as an assistant professor in the Division of Hematology.
During my fellowship, I received the Conquer Cancer Foundation Young Investigator Award, the American Society of Hematology Clinical Research Training Institute Award and a T32 Research Training Grant from the National Institutes of Health. Since I’ve been on faculty, I have received the American Society of Hematology Clinical Scholar Award and the Alliance Foundation Clinical Scholar Award, both for research support.
As a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, my research interests include studying the effectiveness of novel therapeutics on patients with AML and other myeloid neoplasms. I have authored multiple clinical trial proposals in AML and have been the site principal investigator (PI) for investigator-initiated and industry-supported AML studies in both upfront and relapsed/refractory disease.
I am currently the lead PI on a multi-center study investigating novel treatment in elderly AML patients though the Leukemia & Lymphoma Society Beat AML Master Trial. Additionally, my work has been published in several well-respected journals, including Molecular Pharmacology, Leukemia and Blood.
I feel privileged to be part of the Ohio State medical community, and I’m especially proud to contribute to the work we do here at the OSUCCC – James. We all share a common goal: to provide cutting-edge research that will lead to a cancer-free world and deliver superior, individualized care to each and every one of our patients.
Highlights
- Named to Castle Connolly's Regional Top Doctors list
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2017
Procedures and Conditions I Treat
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Acute Myeloid Leukemias
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
- Myelodysplastic Syndromes
Education and Training
Education History
Medical School
Medical University of South Carolina College of Medicine, Charleston, SC
8/1/2001 - 5/20/2005
Residency
Wake Forest University Baptist Medical Center, Winston Salem, NC
6/1/2005 - 6/30/2008
Fellowship
Ohio State University Wexner Medical Center, Columbus, OH
7/1/2009 - 6/30/2012
Board Certification
American Board of Internal Medicine/Medical Oncology
10/24/2012
Academic Information
My Department
Internal Medicine
My Division
Hematology
Reviews
The overall patient satisfaction rating is an average of all patient responses to the six doctor communication related questions shown below from the Clinician and Group Consumer Assessment of Healthcare Providers and Systems survey. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page.
The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of Ohio State Wexner Medical Center.
110 Patient Satisfaction Reviews
-
Overall
4.9 out of 5
-
Kept you informed about your condition and treatment
4.9 out of 5
-
Amount of time spent with you
4.9 out of 5
-
Concern for your questions and issues
4.9 out of 5
-
Skill and knowledge
4.9 out of 5
-
Overall quality of care
4.9 out of 5
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 09/30/2022, Dr. Mims has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.
- Rigel Pharmaceuticals
- Jazz Pharmaceuticals
- Bristol Myers Squibb
- AbbVie
- Vincerx Pharma
- Foghorn Therapeutics, Inc.
Best care, my experience at OSU since 2017 has been the best, I my alive today thanks to them
Dr Mims and her staff very good happy Dr Mims is my doctor
Loved Dr Mims
Dr. Mims is excellent!
The care I receive from Dr. Mims and the staff at the James is fantastic. From scheduling my appointment to meeting with my Doctor I get great care. I would recommend this hospital to everyone.
All good.
Dr. Alice Mims is a great asset to the James, and the hematology department. I have a great level of trust in her care and capabilities.
Dr. Mims & staff are all very nice & caring. I would highly recommend her to others.
ALL GOOD
The phlebotomist (who 95% of the time takes my blood) is awesome!! Lucky to have her! Nurses are super nice & helpful. Dr. Mims is very caring & takes her time with me!!
Still undergoing tests. Treatment has not been discussed yet as diagnosis is uncertain. Dr. Mims was compassionate throughout the appointment & did not hurry me.
I have a new diagnosis and Dr Mims was patient, comforting and answered all of my questions.
Dr. Mims always takes her time with me and explains everything thoroughly she is a treasure to The James research center